Efficacy and auditory biomarker analysis of fronto-temporal transcranial direct current stimulation (tDCS) in targeting cognitive impairment associated with recent-onset schizophrenia: study protocol for a multicenter randomized double-blind sham-controlled trial

[1]  M. Polosan,et al.  Experience, impact and needs of informal parental caregivers around the communication of a diagnosis of schizophrenia , 2022, The International journal of social psychiatry.

[2]  M. Chupin,et al.  Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM’Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial , 2021, Trials.

[3]  K. Sim,et al.  Adjunctive multi-session transcranial direct current stimulation for neurocognitive dysfunction in schizophrenia: A meta-analysis. , 2021, Asian journal of psychiatry.

[4]  J. Brunelin,et al.  tDCS as a first-choice agent in individuals at high-risk for psychosis? , 2021, L'Encephale.

[5]  Darrin J. Lee,et al.  Transcranial Direct Current Stimulation for Schizophrenia: A Meta-Analysis , 2021, Biological Psychiatry.

[6]  Chen Zhang,et al.  Efficacy of transcranial direct current stimulation in ameliorating negative symptoms and cognitive impairments in schizophrenia: A systematic review and meta-analysis , 2020, Schizophrenia Research.

[7]  S. Kymes,et al.  A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States , 2020, PloS one.

[8]  J. Brunelin,et al.  Cognitive insight in individuals with an at‐risk mental state for psychosis: A meta‐analysis , 2020, Early intervention in psychiatry.

[9]  G. Thut,et al.  Targeting cognition in schizophrenia through transcranial direct current stimulation: A systematic review and perspective , 2020, Schizophrenia Research.

[10]  A. Brunoni,et al.  Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial. , 2020, JAMA psychiatry.

[11]  J. Brunelin,et al.  Validation of the French Version of the Auditory Hallucination Rating Scale in a Sample of Hallucinating Patients with Schizophrenia , 2019, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[12]  A. Koyanagi,et al.  Effect of multi-session prefrontal transcranial direct current stimulation on cognition in schizophrenia: A systematic review and meta-analysis , 2019, Schizophrenia Research.

[13]  D. Javitt,et al.  Neural and functional correlates of impaired reading ability in schizophrenia , 2019, Scientific Reports.

[14]  D. Javitt,et al.  Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia , 2019, Translational Psychiatry.

[15]  D. Javitt,et al.  A century of sensory processing dysfunction in schizophrenia , 2019, European Psychiatry.

[16]  A. Gadelha,et al.  Evaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial , 2019, Trials.

[17]  D. Javitt,et al.  Hierarchical deficits in auditory information processing in schizophrenia , 2019, Schizophrenia Research.

[18]  Anthonin Reilhac,et al.  Development of a Dedicated Rebinner with Rigid Motion Correction for the mMR PET/MR Scanner, and Validation in a Large Cohort of 11C-PIB Scans , 2018, The Journal of Nuclear Medicine.

[19]  C. Herbert,et al.  The spatio-temporal dynamics of deviance and target detection in the passive and active auditory oddball paradigm: a sLORETA study , 2018, BMC Neuroscience.

[20]  D. Javitt,et al.  Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia , 2018, Schizophrenia Research.

[21]  J. Brunelin,et al.  Tone-matching ability in patients with schizophrenia: A systematic review and meta-analysis , 2017, Schizophrenia Research.

[22]  Marc Recasens,et al.  The 40-Hz Auditory Steady-State Response in Patients With Schizophrenia: A Meta-analysis. , 2016, JAMA psychiatry.

[23]  Pejman Sehatpour,et al.  Neural mechanisms of mismatch negativity (MMN) dysfunction in schizophrenia , 2016, Molecular Psychiatry.

[24]  S. Dollfus,et al.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms. , 2016, Schizophrenia bulletin.

[25]  Daniel C. Javitt,et al.  Auditory dysfunction in schizophrenia: integrating clinical and basic features , 2015, Nature Reviews Neuroscience.

[26]  Seena Fazel,et al.  Risks of all‐cause and suicide mortality in mental disorders: a meta‐review , 2014, World psychiatry : official journal of the World Psychiatric Association.

[27]  A. Vita,et al.  Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia , 2013, Schizophrenia Research.

[28]  Mohamed Saoud,et al.  Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. , 2012, The American journal of psychiatry.

[29]  Michael F. Green,et al.  The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? , 2011, Schizophrenia bulletin.

[30]  F. Fregni,et al.  A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. , 2011, The international journal of neuropsychopharmacology.

[31]  S. Marder,et al.  The brief negative symptom scale: psychometric properties. , 2011, Schizophrenia bulletin.

[32]  A. Loundou,et al.  The development of the S-QoL 18: A shortened quality of life questionnaire for patients with schizophrenia , 2010, Schizophrenia Research.

[33]  D. Javitt.  Sensory processing in schizophrenia: neither simple nor intact. , 2009, Schizophrenia bulletin.

[34]  H. Caci,et al.  The “Functional Remission of General Schizophrenia” (FROGS) scale: Development and validation of a new questionnaire , 2009, Schizophrenia Research.

[35]  D. Javitt.  When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. , 2009, Annual review of clinical psychology.

[36]  Y. Khazaal,et al.  The Beck Cognitive Insight Scale in Outpatients with Psychotic Disorders: Further Evidence from a French-Speaking Sample , 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[37]  Michael F. Green,et al.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. , 2008, The American journal of psychiatry.

[38]  Michael F. Green,et al.  The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. , 2008, The American journal of psychiatry.

[39]  R. Keefe.  Cognitive deficits in patients with schizophrenia: effects and treatment. , 2007, The Journal of clinical psychiatry.

[40]  Bruno Falissard,et al.  The improved Clinical Global Impression Scale (iCGI): development and validation in depression , 2007, BMC psychiatry.

[41]  H. Ellis,et al.  The Cardiff Anomalous Perceptions Scale (CAPS): a new validated measure of anomalous perceptual experience. , 2006, Schizophrenia bulletin.

[42]  Philip D. Harvey,et al.  Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine. , 2006, The Journal of neuropsychiatry and clinical neurosciences.

[43]  John H. Krystal,et al.  Temporoparietal Transcranial Magnetic Stimulation for Auditory Hallucinations: Safety, Efficacy and Moderators in a Fifty Patient Sample , 2005, Biological Psychiatry.

[44]  A. Beck,et al.  A new instrument for measuring insight: the Beck Cognitive Insight Scale , 2004, Schizophrenia Research.

[45]  E. Stip,et al.  Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia. , 2003, Comprehensive psychiatry.

[46]  Ronan E. O'Carroll,et al.  Cognitive impairment in schizophrenia , 2000 .

[47]  M. Gladis,et al.  Family burden of schizophrenia and bipolar disorder: perceptions of relatives and professionals. , 1996, Psychiatric services.

[48]  N. Cowan,et al.  Auditory sensory ("echoic") memory dysfunction in schizophrenia. , 1995, The American journal of psychiatry.

[49]  J. Addington,et al.  Assessing Depression in Schizophrenia: The Calgary Depression Scale , 1993, British Journal of Psychiatry.

[50]  S. Sheather,et al.  Clinical applications of visual analogue scales: a critical review , 1988, Psychological Medicine.

[51]  Michael F. Green,et al.  Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia , 2017, JAMA psychiatry.

[52]  M. Linden,et al.  Assessing Anomalous Perceptions in Youths: A Preliminary Validation Study of the Cardiff Anomalous Perception Scale (CAPS) , 2011 .

[53]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[54]  C. Lançon,et al.  [Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)]. , 2000, L'Encephale.

[55]  W A Hargreaves,et al.  Clozapine eligibility among state hospital patients. , 1996, Schizophrenia bulletin.

[56]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.